CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the Revascularization of left main coronary artery Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

Original Research2020 Oct 3.

JOURNAL:Eur J Nucl Med Mol Imaging. Article Link

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension

A Frille, M Rullmann, S Hesse & HJ Seyfarth et al. Keywords: pulmonary serotonin transporter; PH; chronic obstructive pulmonary disease

FULL TEXT PDF